Picture of Bruker logo

BRKR Bruker Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapFalling Star

Annual cashflow statement for Bruker, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line161281299429114
Depreciation
Deferred Taxes
Non-Cash Items43.344.146-81.195.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital69.6-126-144-87.8-78.2
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities332282274350251
Capital Expenditures-97.2-92-129-107-115
Purchase of Fixed Assets
Other Investing Cash Flow Items-95.5-100-122-219-1,642
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-193-192-252-326-1,757
Financing Cash Flow Items-8.8-0.5-14.50.3-24.9
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-162319-415-1931,230
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3.6386-423-157-305